Leslie  Trigg net worth and biography

Leslie Trigg Biography and Net Worth

Leslie Trigg has served as Outset’s Chief Executive Officer and as a member of the board of directors since November 2014.  Leslie joined Outset from Warburg Pincus where she was an Executive in Residence. Previously, she was Executive Vice President at Lutonix, a cardiovascular medical device company acquired by CR Bard. Prior to Lutonix, Leslie served as Chief Business Officer of AccessClosure, a vascular closure company acquired by Cardinal Health. Before joining AccessClosure, Leslie served as Vice President, Marketing for FoxHollow Technologies, helping to architect the strategy and commercial infrastructure that led to a successful IPO and subsequent acquisition by ev3/Covidien. Leslie’s management experience also includes senior leadership positions at Cytyc Corporation and breast cancer diagnostics company Pro-Duct Health, Inc., which was acquired by Cytyc. She began her medical device career at Guidant Corporation. 
Leslie received her undergraduate degree from Northwestern University and her MBA from the Haas School of Business, UC Berkeley.

What is Leslie Trigg's net worth?

The estimated net worth of Leslie Trigg is at least $573.06 thousand as of November 17th, 2025. Ms. Trigg owns 121,412 shares of Outset Medical stock worth more than $573,065 as of December 5th. This net worth evaluation does not reflect any other investments that Ms. Trigg may own. Additionally, Ms. Trigg receives an annual salary of $1,220,000.00 as CEO at Outset Medical. Learn More about Leslie Trigg's net worth.

How old is Leslie Trigg?

Ms. Trigg is currently 53 years old. There are 5 older executives and no younger executives at Outset Medical. Learn More on Leslie Trigg's age.

What is Leslie Trigg's salary?

As the CEO of Outset Medical, Inc., Ms. Trigg earns $1,220,000.00 per year. Learn More on Leslie Trigg's salary.

How do I contact Leslie Trigg?

The corporate mailing address for Ms. Trigg and other Outset Medical executives is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. Outset Medical can also be reached via phone at 669-231-8200 and via email at [email protected]. Learn More on Leslie Trigg's contact information.

Has Leslie Trigg been buying or selling shares of Outset Medical?

Within the last three months, Leslie Trigg has sold $4,213.60 in Outset Medical stock. Most recently, Leslie Trigg sold 916 shares of the business's stock in a transaction on Monday, November 17th. The shares were sold at an average price of $4.60, for a transaction totalling $4,213.60. Following the completion of the sale, the chief executive officer now directly owns 121,412 shares of the company's stock, valued at $558,495.20. Learn More on Leslie Trigg's trading history.

Who are Outset Medical's active insiders?

Outset Medical's insider roster includes Nabeel Ahmed (VP), John Brottem (General Counsel), Rebecca Chambers (CFO), D. Grossman (Director), James Hinrichs (Director), Marc Nash (SVP), Leslie Trigg (CEO), Martin Vazquez (COO), and Steven Williamson (Insider). Learn More on Outset Medical's active insiders.

Are insiders buying or selling shares of Outset Medical?

In the last year, insiders at the sold shares 23 times. They sold a total of 24,777 shares worth more than $297,113.91. The most recent insider tranaction occured on December, 1st when Director Karen Drexler sold 1,548 shares worth more than $6,764.76. Insiders at Outset Medical own 2.4% of the company. Learn More about insider trades at Outset Medical.

Information on this page was last updated on 12/1/2025.

Leslie Trigg Insider Trading History at Outset Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2025Sell916$4.60$4,213.60121,412View SEC Filing Icon  
5/15/2025Sell935$17.80$16,643.0058,129View SEC Filing Icon  
2/18/2025Sell974$13.50$13,149.0058,731View SEC Filing Icon  
1/21/2025Sell4,349$12.00$52,188.0059,705View SEC Filing Icon  
1/13/2025Sell2,215$12.15$26,912.2557,426View SEC Filing Icon  
1/7/2025Sell681$19.35$13,177.3559,641View SEC Filing Icon  
11/15/2024Sell376$12.00$4,512.0060,323View SEC Filing Icon  
8/15/2024Sell353$12.60$4,447.8060,699View SEC Filing Icon  
5/16/2024Sell349$52.95$18,479.5561,053View SEC Filing Icon  
2/15/2024Sell354$53.55$18,956.7055,539View SEC Filing Icon  
1/16/2024Sell541$64.35$34,813.3555,894View SEC Filing Icon  
1/8/2024Sell945$82.35$77,820.7525,939View SEC Filing Icon  
7/3/2023Sell1,333$313.50$417,895.5027,299View SEC Filing Icon  
6/1/2023Sell1,333$316.50$421,894.5027,299View SEC Filing Icon  
5/16/2023Sell197$298.65$58,834.0527,299View SEC Filing Icon  
5/3/2023Sell2,666$300.00$799,800.0027,496View SEC Filing Icon  
3/1/2023Sell2,000$337.20$674,400.0027,496View SEC Filing Icon  
2/16/2023Sell201$365.40$73,445.4027,401View SEC Filing Icon  
2/1/2023Sell2,000$420.90$841,800.0027,602View SEC Filing Icon  
1/27/2023Sell418$418.80$175,058.4027,602View SEC Filing Icon  
1/3/2023Sell2,000$378.90$757,800.0019,349View SEC Filing Icon  
12/1/2022Sell2,000$312.75$625,500.0019,349View SEC Filing Icon  
11/11/2022Sell2,000$300.00$600,000.0019,410View SEC Filing Icon  
8/16/2022Sell60$322.20$19,332.0019,410View SEC Filing Icon  
8/1/2022Sell2,000$300.00$600,000.0019,471View SEC Filing Icon  
6/1/2022Sell2,000$314.25$628,500.0019,471View SEC Filing Icon  
5/17/2022Sell60$395.40$23,724.0019,471View SEC Filing Icon  
5/2/2022Sell2,000$538.05$1,076,100.0019,532View SEC Filing Icon  
4/1/2022Sell4,333$692.70$3,001,469.1019,532View SEC Filing Icon  
3/16/2022Sell242$596.55$144,365.10View SEC Filing Icon  
3/1/2022Sell1,333$652.35$869,582.55View SEC Filing Icon  
1/3/2022Sell2,833$706.50$2,001,514.50View SEC Filing Icon  
12/1/2021Sell1,333$708.60$944,563.80View SEC Filing Icon  
11/1/2021Sell2,333$846.15$1,974,067.95View SEC Filing Icon  
10/1/2021Sell2,833$730.50$2,069,506.50View SEC Filing Icon  
9/17/2021Sell1,000$825.00$825,000.00View SEC Filing Icon  
9/1/2021Sell1,333$737.40$982,954.2017,683View SEC Filing Icon  
7/1/2021Sell2,833$738.75$2,092,878.7517,543View SEC Filing Icon  
5/3/2021Sell1,333$870.75$1,160,709.7518,043View SEC Filing Icon  
4/1/2021Sell3,833$830.85$3,184,648.0518,294View SEC Filing Icon  
See Full Table

Leslie Trigg Buying and Selling Activity at Outset Medical

This chart shows Leslie Trigg's buying and selling at Outset Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Outset Medical Company Overview

Outset Medical logo
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Read More

Today's Range

Now: $4.72
Low: $4.16
High: $4.79

50 Day Range

MA: $10.54
Low: $4.05
High: $15.81

2 Week Range

Now: $4.72
Low: $4.00
High: $25.35

Volume

627,131 shs

Average Volume

814,952 shs

Market Capitalization

$85.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.03